Skip to main content
Erschienen in: European Journal of Plastic Surgery 1/2005

01.08.2005 | Original Paper

The perioperative management of patients on antiplatelet agents and anticoagulants presenting for plastic surgical operations: a survey of current practice in the UK

verfasst von: D. Oudit, G. Ross, M. Ellabban, H. Khan, D. Eldafl, A. Juma

Erschienen in: European Journal of Plastic Surgery | Ausgabe 1/2005

Einloggen, um Zugang zu erhalten

Abstract

A significant proportion of patients who present for plastic surgical procedures take aspirin or other antiplatelet agents (clopidogrel or nonsteroidal anti-inflammatory drugs) or are on anticoagulants (e.g. warfarin). Although there have been several reports in the literature regarding the perioperative management of patients presenting for dermatologic surgery, there have been no such reports pertaining to the wider scope of plastic surgical practice. In the absence of clear guidelines for the perioperative management of these patients presenting for plastic surgical practice, we have undertaken a pilot survey of the current practices of consultant plastic surgeons in the UK. The aims of this study were to determine whether there was uniformity of practice, and whether the modes of practice differed from those outlined in the literature for other related specialities. A postal survey of 235 plastic surgical consultants was conducted. The response rate was 48%. Overall, most respondents (84%) stated that their practice was primarily based on personal preference, and only 28% stated that it was based on the local Unit policy. Only 23% of the Consultants based their practice on evidence-based medicine. There appeared to be significant variations in current practice amongst plastic surgeons. Some aspects of practice were found to vary from those recommended in the literature for other related specialities. We hope that the findings of this study will highlight the significant non-uniformity of practice within this speciality and that this may form the basis for the development of clear guidelines of the entire spectrum of plastic surgery for the preoperative management of this group of patients in the future.
Literatur
1.
Zurück zum Zitat Bartlett Gr (1999) Does aspirin affect the outcome of minor cutaneous surgery? Br J Plast Surg 52: 214–216 Bartlett Gr (1999) Does aspirin affect the outcome of minor cutaneous surgery? Br J Plast Surg 52: 214–216
2.
Zurück zum Zitat Kovich O, Otley C (2003) Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation. J Am Acad Dermatol 48: 233–37 Kovich O, Otley C (2003) Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation. J Am Acad Dermatol 48: 233–37
3.
Zurück zum Zitat Alam M, Goldberg LH (2002) Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy. Dermatol Surg. 28(110):992–998 Alam M, Goldberg LH (2002) Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy. Dermatol Surg. 28(110):992–998
4.
Zurück zum Zitat Otley CC, Fewkes J, Frank W, Olbricht S (1996) Complications of cutaneous surgery in patients who are taking warfarin, aspirin or nonsteroidal anti-inflammatory drugs. Arch Dermatol. 132:161–166 Otley CC, Fewkes J, Frank W, Olbricht S (1996) Complications of cutaneous surgery in patients who are taking warfarin, aspirin or nonsteroidal anti-inflammatory drugs. Arch Dermatol. 132:161–166
5.
Zurück zum Zitat Ferraris VA, Ferraris SP, Joseph O, Wehner P, Mentzer RM (2002) Aspirin and postoperative bleeding after coronary artery bypass grafting. Ann Surg 235(6): 820–827 Ferraris VA, Ferraris SP, Joseph O, Wehner P, Mentzer RM (2002) Aspirin and postoperative bleeding after coronary artery bypass grafting. Ann Surg 235(6): 820–827
6.
Zurück zum Zitat Gibbs NM, Weightman WM, Thackray NM, Michelopoulos N, Weidman C (2001) The effects of recent aspirin ingestion on platelet function in cardiac surgical patients. J Cardiothorac Vasc Anaes 15(1):55–59 Gibbs NM, Weightman WM, Thackray NM, Michelopoulos N, Weidman C (2001) The effects of recent aspirin ingestion on platelet function in cardiac surgical patients. J Cardiothorac Vasc Anaes 15(1):55–59
7.
Zurück zum Zitat Kargi E, Babuccu O, Hosnuter M, Babuccu B, Altinyazar C (2002) Complications of minor cutaneous surgery in patients under anticoagulant treatment. Aesth Plast Surg 26:483–485 Kargi E, Babuccu O, Hosnuter M, Babuccu B, Altinyazar C (2002) Complications of minor cutaneous surgery in patients under anticoagulant treatment. Aesth Plast Surg 26:483–485
8.
Zurück zum Zitat Lawrence C, Sakuntabhai A, Tiling-Grosse S (1994) Effect of aspirin and nonsteroidal anti-inflammatory drug therapy on bleeding complications in dermatologic surgical patients. J Am Acad Dermatol 31(6): 988–992 Lawrence C, Sakuntabhai A, Tiling-Grosse S (1994) Effect of aspirin and nonsteroidal anti-inflammatory drug therapy on bleeding complications in dermatologic surgical patients. J Am Acad Dermatol 31(6): 988–992
9.
Zurück zum Zitat Smout J, Stansby G (2003) Current practice of in the use of antiplatelet agents in the perioperative period by UK vascular surgeons. Ann R Coll Surg Engl 85: 97–101 Smout J, Stansby G (2003) Current practice of in the use of antiplatelet agents in the perioperative period by UK vascular surgeons. Ann R Coll Surg Engl 85: 97–101
10.
Zurück zum Zitat Otley CC (2003) Continuation of medically necessary aspirin and warfarin during cutaneous surgery. Mayo Clin Proc 78:1392–1396 Otley CC (2003) Continuation of medically necessary aspirin and warfarin during cutaneous surgery. Mayo Clin Proc 78:1392–1396
11.
Zurück zum Zitat Billingsley EM, Maloney ME (1997) Intraoperative and postoperative bleeding problems in patients taking warfarin, aspirin and nonsteroidal anti-inflammatory agents. Dermatol Surg 23:381–385 Billingsley EM, Maloney ME (1997) Intraoperative and postoperative bleeding problems in patients taking warfarin, aspirin and nonsteroidal anti-inflammatory agents. Dermatol Surg 23:381–385
12.
Zurück zum Zitat Stables G, Lawrence CM (2002) Management of patients taking anticoagulant, aspirin, non-steroidal anti-inflammatory and other platelet drugs undergoing dermatological surgery. Clin Exp Dermatol 27:432–435 Stables G, Lawrence CM (2002) Management of patients taking anticoagulant, aspirin, non-steroidal anti-inflammatory and other platelet drugs undergoing dermatological surgery. Clin Exp Dermatol 27:432–435
13.
Zurück zum Zitat DeMere M, Wood T, Austin W (1974) Eye complications with blepharoplasty or other eyelid surgery. Plast Reconstr Surg 53(6):634–37 DeMere M, Wood T, Austin W (1974) Eye complications with blepharoplasty or other eyelid surgery. Plast Reconstr Surg 53(6):634–37
14.
Zurück zum Zitat Goldsmith SM, Leshin B, Owen J (1993) Management of patients taking anticoagulants and platelet inhibitors prior to dermatological surgery. Dermatol Surg Oncol 19:578–581 Goldsmith SM, Leshin B, Owen J (1993) Management of patients taking anticoagulants and platelet inhibitors prior to dermatological surgery. Dermatol Surg Oncol 19:578–581
15.
Zurück zum Zitat Fischman JR (2002) Should aspirin be discontinued 2 weeks before elective surgery? Plast Reconstr Surg 109(5):1746–1747 Fischman JR (2002) Should aspirin be discontinued 2 weeks before elective surgery? Plast Reconstr Surg 109(5):1746–1747
16.
Zurück zum Zitat Hardman JH, Limbird LE (eds) (1996) Goodman and Gilman’s ‘The pharmacological basis of therapeutics’ 9th edn. Mc Graw-Hill, USA, p 627 Hardman JH, Limbird LE (eds) (1996) Goodman and Gilman’s ‘The pharmacological basis of therapeutics’ 9th edn. Mc Graw-Hill, USA, p 627
Metadaten
Titel
The perioperative management of patients on antiplatelet agents and anticoagulants presenting for plastic surgical operations: a survey of current practice in the UK
verfasst von
D. Oudit
G. Ross
M. Ellabban
H. Khan
D. Eldafl
A. Juma
Publikationsdatum
01.08.2005
Erschienen in
European Journal of Plastic Surgery / Ausgabe 1/2005
Print ISSN: 0930-343X
Elektronische ISSN: 1435-0130
DOI
https://doi.org/10.1007/s00238-005-0721-7

Weitere Artikel der Ausgabe 1/2005

European Journal of Plastic Surgery 1/2005 Zur Ausgabe

Forthcoming Meetings & Events

Forthcoming Meetings 28/1

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.